In breast cancer, STIM1 and STIM2 contribute to invasion, migration, and SOC-dependent TGFβ-mediated EMT (epithelial-mesenchymal transition), and their overexpression significantly correlates with the poor survival [47]. This evidence concerns the gene STIM1 and breast carcinoma.